Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction
Primary Purpose
Rectal Prolapse, Pelvic Organ Prolapse
Status
Unknown status
Phase
Phase 4
Locations
Switzerland
Study Type
Interventional
Intervention
Minimally invasive rectopexy
Sponsored by
About this trial
This is an interventional treatment trial for Rectal Prolapse
Eligibility Criteria
Inclusion Criteria:
- women
- proven pelvic floor dysfunction
- informed consent
Exclusion Criteria:
- Age <18 years old
- Patient unable to communicate or to understand the study
- Patient refusing to participate to the study
- contraindication to laparoscopy
Sites / Locations
- University Hospital of Geneva, Department of SurgeryRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Robotic
Laparoscopy
Arm Description
Use of daVinci surgical system (Intuitive Surgical Inc, Sunnyvale, CA) for the treatment of complex pelvic floor dysfunction
Use of standard laparoscopy for the treatment of complex pelvic floor dysfunction
Outcomes
Primary Outcome Measures
Perioperative outcomes
Including: blood loss, operative time, conversion rate, quality of dissection, pain, complications, hospital stay.
Secondary Outcome Measures
Functional results
Constipation score Incontinence score Quality of life score Sexuality score
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01346436
Brief Title
Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction
Official Title
Randomized Double Blind Controlled Trial of the Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Unknown status
Study Start Date
April 2011 (undefined)
Primary Completion Date
May 2020 (Anticipated)
Study Completion Date
May 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Nicolas C. Buchs
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this randomized double blind controlled study is to assess the value of robotics for the treatment of complex pelvic floor dysfunction. The main aim is to compare perioperative and functional outcomes to the laparoscopic approach.
Detailed Description
Pelvic floor dysfunction is a common pathology. The management can be medical or surgical, depending on the location or the severity of the disease.
Since the large use of laparoscopy for the treatment of pelvic floor dysfunction, interesting and encouraging results have been published.
However, so far, a laparoscopic approach has some technical disadvantages like a poor ergonomy, a 2 dimensional vision, an unstable camera and the use of straight instruments. To overcome these natural limitations, robotics has been gaining increasing acceptance in general surgery.
Several groups have reported their encouraging experience with robotic rectopexy. Yet, these studies were not randomized or double blinded.
The aim of this study is to evaluate the role of robotics for complex pelvic floor dysfunction and to compare the outcomes to the laparoscopic approach.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectal Prolapse, Pelvic Organ Prolapse
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Robotic
Arm Type
Active Comparator
Arm Description
Use of daVinci surgical system (Intuitive Surgical Inc, Sunnyvale, CA) for the treatment of complex pelvic floor dysfunction
Arm Title
Laparoscopy
Arm Type
Active Comparator
Arm Description
Use of standard laparoscopy for the treatment of complex pelvic floor dysfunction
Intervention Type
Procedure
Intervention Name(s)
Minimally invasive rectopexy
Other Intervention Name(s)
Surgery for rectal prolapse
Intervention Description
Use of a minimally invasive approach (robotic or laparoscopy) to perform a rectopexy
Primary Outcome Measure Information:
Title
Perioperative outcomes
Description
Including: blood loss, operative time, conversion rate, quality of dissection, pain, complications, hospital stay.
Time Frame
up to 30 days
Secondary Outcome Measure Information:
Title
Functional results
Description
Constipation score Incontinence score Quality of life score Sexuality score
Time Frame
At 12 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
women
proven pelvic floor dysfunction
informed consent
Exclusion Criteria:
Age <18 years old
Patient unable to communicate or to understand the study
Patient refusing to participate to the study
contraindication to laparoscopy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nicolas C Buchs, MD
Phone
+41 79 553 2683
Email
nicolas.c.buchs@hcuge.ch
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolas C Buchs, MD
Organizational Affiliation
University Hospital, Geneva
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital of Geneva, Department of Surgery
City
Geneva
ZIP/Postal Code
1211
Country
Switzerland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicolas C Buchs, MD
Phone
+41 553 2683
Email
nicolas.c.buchs@hcuge.ch
First Name & Middle Initial & Last Name & Degree
Nicolas C Buchs, MD
First Name & Middle Initial & Last Name & Degree
Bruno Roche, MD
First Name & Middle Initial & Last Name & Degree
François Pugin, MD
First Name & Middle Initial & Last Name & Degree
Pascal Bucher, MD
First Name & Middle Initial & Last Name & Degree
Karel Skala, MD
First Name & Middle Initial & Last Name & Degree
Frédéric Ris, MD
First Name & Middle Initial & Last Name & Degree
Monika Hagen, MD
First Name & Middle Initial & Last Name & Degree
Guillaume Zufferey, MD
First Name & Middle Initial & Last Name & Degree
Philippe Morel, MD
12. IPD Sharing Statement
Learn more about this trial
Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction
We'll reach out to this number within 24 hrs